although gene base duchess muscular dystrophy known almost thirty year cellular molecular meghan character disease complete understood efficacy treatment remain develop studi analyze proteam data obtain somalia technology blood serum cohort patient match health subject workflow base biomass identify networks pathway analysis allow unit state describe differ deregul pathway admit musclerel function identify biology process apoptosis signal immune system neurotrophin significantly model compare control more involve fox transcript factor put regal whole provide global view involve decipher proteam 